Xylose versus Bacteroides in graft-versus-host

Area of Science:

• Microbiology
• Immunology
• Gastroenterology

Background:

• Graft-versus-host disease (GVHD) is a serious complication of hematopoietic cell transplantation.
• The gut microbiome plays a critical role in modulating GVHD severity.
• Antibiotic use in transplant patients can disrupt the gut microbiota.

Purpose of the Study:

• To elucidate the mechanistic link between carbapenem antibiotics and GVHD.
• To identify microbial factors contributing to antibiotic-induced GVHD exacerbation.
• To explore therapeutic strategies for mitigating antibiotic-associated GVHD.

Main Methods:

• Investigated the impact of carbapenem treatment on gut microbiota composition and function in a mouse model.
• Assessed colonic mucus integrity and bacterial adherence.
• Evaluated the effect of xylose supplementation on mucus degradation, bacterial translocation, and GVHD outcomes.

Main Results:

• Carbapenem treatment led to the degradation of colonic mucus by *Bacteroides thetaiotaomicron*.
• This mucus degradation was associated with increased bacterial translocation and GVHD severity.
• Xylose administration reversed mucus degradation, reduced bacterial translocation, and decreased mortality.

Conclusions:

• *Bacteroides thetaiotaomicron* contributes to carbapenem-induced GVHD by degrading colonic mucus.
• Xylose acts as a prebiotic, protecting the colonic mucus barrier and ameliorating GVHD.
• Targeting the gut microbiome, specifically mucus degradation, offers a potential therapeutic avenue for GVHD.